London, UK, 9 October 2007. Plasticell Ltd is delighted to note that Sir Martin Evans, a founding member of the company’s Scientific Advisory Board, has been awarded this year’s Nobel Prize in Physiology or Medicine together with Mario Capecchi and Oliver Smithies for their discoveries of "principles for introducing specific gene modifications in mice by the use of embryonic stem [...]

London, UK, 24 September 2007. Plasticell, the biotechnology company developing regenerative drugs using high throughput stem cell technologies, has entered into an agreement with Hamilton Company, a worldwide leader in robotic liquid handling devices and laboratory automation, to automate Plasticell’s Combinatorial Cell Culture™ technology for the determination of optimal protocols to direct stem cell differentiation. Plasticell and Hamilton will develop [...]

London, UK, 25 January 2007. Plasticell Ltd, the UK biotechnology company developing drugs to regenerate tissues of the body, announced today that it has secured a £1.1m Technology Programme grant from the Department of Trade & Industry (DTI), to support a three year collaborative research and development project entitled “A technology to ensure optimum cell performance for regenerative medicine”. Plasticell [...]

London, UK, 2 Jan 2007. Plasticell Ltd, the UK biotechnology company developing drugs to regenerate tissues of the body, has relocated its offices and laboratories to the newly opened Imperial BioIncubator, a facility managed by Imperial Innovations and sited at Imperial College London’s South Kensington campus. Plasticell is the first external company to be admitted to the BioIncubator and joins [...]

London UK, 22 May 2006. Plasticell Ltd, the UK biotechnology company developing drugs to regenerate tissues of the body, has appointed Christopher Adam to its board. He will assist the company with corporate and product development strategies. Mr Adam brings over 35 years of board level and operational experience in the pharmaceutical industry to Plasticell. He has sat on the executive committee of [...]

London, UK, 9 June 2004. Plasticell Ltd, a seed stage biotechnology company developing high throughput technology for stem cell research, today announced it has closed its first equity financing round after securing over £0.5m from angel investors including a syndicate comprising private clients of the financial services group Williams de Broë. The company will lease dedicated laboratories in the Medical [...]

London, UK, 1 December 2002. A UK-based, start-up biotechnology company, Plasticell Ltd, has been created to commercialise an innovative high throughput technology for cell biology. Plasticell was founded by scientist and entrepreneur Dr Yen Choo and owns intellectual property drawn to Combinatorial Cell Culture™, a bead-based high throughput screening system for the discovery of serial cell culture protocols that are [...]